| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | ML 385 |
|---|
| Description | Nrf2 inhibitor. Blocks Nrf2 downstream target gene expression. Enhances cytotoxic effects of doxorubicin (Cat. No. 2252) or Taxol (Cat. No. 1097) in non-small cell lung cancer (NSCLC). Demonstrates selectivity for NSCLC cells with KEAP1 mutations. Purity 98%. MW (observed): 511.59 |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[4-[2,3-Dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]-1,3-benzodioxole-5-acetamide |
|---|
| Gene, Accession, CAS # | CAS: 846557-71-9 |
|---|
| Catalog # | 6243/25 |
|---|
| Price | |
|---|
| Order / More Info | ML 385 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|